BIDIL
Generic: HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE
Azurity PharmaceuticalsManufacturer
ORALRoute
HYDRALAZINE HYDROCHLORIDEActive Substance
2005-06-23Original Approval
BIDIL is FDA application NDA020727, sponsored by AZURITY. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DISCOMFORT
1 reports
2
PRODUCT TASTE ABNORMAL
1 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
1 reports